American Academy of Pediatrics
This article was originally published in The Tan Sheet
Executive Summary
Recommends in a folic acid policy statement that FDA "expeditiously devise and implement a program, such as fortification, that will prevent" neural tube defects. Such a program, AAP advised, should support a surveillance system to track the "effectiveness and/or adverse outcomes" of fortification. FDA is expected within the next month to issue a proposal allowing folic acid health claims as well as fortification of the food supply ("The Tan Sheet" Aug. 16, p. 3).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning